Research and Development

The Research and Development team at Verismo Therapeutics is dedicated to innovating and optimizing chimeric antigen receptor (CAR) therapies to improve T-cell-based immunotherapy for cancer. This team collaborates on translational science and strategic guidance, focusing on the discovery and validation of novel CAR designs and their application in the treatment of non-hematologic malignancies with limited therapeutic options.